SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000891293-12-000028
Filing Date
2012-06-15
Accepted
2012-06-15 20:08:15
Documents
2
Period of Report
2012-06-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1592
2 CONFIRMING STATEMENT poa.txt EX-24 2045
  Complete submission text file 0000891293-12-000028.txt   5015
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Issuer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTINE DESIGN LAB 7967 SKYLINE BLVD OKLAND CA 94611
Business Address
BENNER STEVEN E (Reporting) CIK: 0001242117 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-12465 | Film No.: 12911184